Revance Therapeutics, Inc.
Botulinum toxin and the treatment of primary disorders of mood and affect
Last updated:
Abstract:
A method of treating circadian rhythm disorders includes identifying a subject with a circadian rhythm disorder or at least one symptom of a circadian rhythm disorder and administering an effective amount of a composition comprising a botulinum toxin and a pharmaceutically acceptable carrier to said subject thereby reducing at least one symptom of a circadian rhythm disorder.
Status:
Grant
Type:
Utility
Filling date:
14 Sep 2015
Issue date:
15 Oct 2019